EVERYTHING ABOUT RAW MATERIALS

“The present situation has exposed some structural weaknesses while in the EU’s medicines supply chain plus a significant dependence on non-EU countries for active pharmaceutical ingredients,” Kyriakides explained. She recommended that supply chain troubles be addressed in an EU pharmaceutical technique anticipated being released by the end w